Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

PAVMZ
PAVmed Inc. Series Z Warrant
stock NASDAQ

Inactive
Apr 30, 2025
0.000900USD-40.000%(-0.000600)258,763
Pre-market
0.00USD-100.000%(0.00)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Oct 18, 2021
05:45PM EDT  Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering   GlobeNewswire Inc
Oct 13, 2021
10:15PM EDT  Lucid Diagnostics Announces Pricing of Initial Public Offering   GlobeNewswire Inc
Oct 7, 2021
11:41AM EDT  PAVmed Acquires EsophaCap Manufacturer CapNostics LLC   GlobeNewswire Inc
Jun 14, 2021
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the appointment of prominent global technology industry leader Tim Baxter, to its Board of Directors. Mr. Baxter will serve as Chair of the Companys Nomination Committee and as a member of its Audit Committee.   GlobeNewswire Inc
Jun 10, 2021
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, today announced that its major subsidiary, Lucid Diagnostics Inc. (Lucid), has completed European IVDD CE Mark certification of its EsoGuard Esophageal DNA Test (EsoGuard).   GlobeNewswire Inc
Jun 2, 2021
09:30AM EDT  New subsidiary Verisacquires privately held oncology digital health company Oncodisc Inc.   GlobeNewswire Inc
May 26, 2021
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, and its major subsidiary Lucid Diagnostics Inc. (Lucid), today announced that Lucids EsoCheck Esophageal Cell Collection Device with Collect+Protect technology (EsoCheck) has received CE Mark certification.   GlobeNewswire Inc
May 25, 2021
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has received CE Mark certification for its CarpX minimally invasive carpal tunnel device.   GlobeNewswire Inc
May 24, 2021
09:30AM EDT  Initial NYU experience in 99 patients demonstratedEsoCheck and EsoGuard capable of detectingesophagealprecancerin chronic heartburn patients   GlobeNewswire Inc
May 17, 2021
04:00PM EDT  PAVmed Provides Business Update and First Quarter 2021 Financial   GlobeNewswire Inc
May 13, 2021
09:30AM EDT  Dr. David Poppers to present on his initial experience with Lucids EsoCheck and EsoGuard   GlobeNewswire Inc
May 6, 2021
09:30AM EDT  Four new senior executives will support growth strategy focused on multi-channel EsoGuardcommercialization   GlobeNewswire Inc
May 3, 2021
09:30AM EDT  PAVmed to Hold Business Update Conference Call on May 17, 2021   GlobeNewswire Inc
Apr 29, 2021
09:30AM EDT  Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid   GlobeNewswire Inc
Apr 27, 2021
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the appointment of prominent UK-based global industry executive, Debbie White, to its Board of Directors. Ms. White will serve on the Companys Audit and Compensation Committees.   GlobeNewswire Inc
Apr 15, 2021
09:30AM EDT  PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare   GlobeNewswire Inc
Apr 8, 2021
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmeds Chairman and Chief Executive Officer will present a corporate update at the 20th Annual Needham Healthcare Conference on April 15, 2021 at 8:00 AM EDT.   GlobeNewswire Inc
Mar 10, 2021
09:30AM EST  PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural   GlobeNewswire Inc
Mar 3, 2021
09:30AM EST  PAVmed Retires Convertible Debt   GlobeNewswire Inc
Mar 1, 2021
09:30AM EST  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the Advanced Medical Technology Association (AdvaMed), the worlds leading medical technology trade association, has appointed Lishan Aklog, M.D., PAVmeds Chairman and Chief Executive Officer to its Board of Directors.   GlobeNewswire Inc
Feb 23, 2021
09:00AM EST  PAVmed Announces Pricing of $45 Million Public Offering of Common   GlobeNewswire Inc
Feb 22, 2021
04:13PM EST  PAVmed Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
08:18AM EST  Announces majority-owned subsidiary Lucid Diagnostics intends to spin-off into a separate public company   GlobeNewswire Inc
Feb 18, 2021
09:30AM EST  Conference call and live webcast was previously scheduled for 4:30 PM EST   GlobeNewswire Inc
Feb 16, 2021
09:30AM EST  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the first U.S. patient recently underwent successful carpal tunnel release using its CarpX minimally invasive carpal tunnel device.   GlobeNewswire Inc
Feb 9, 2021
09:30AM EST  PAVmed to Hold Business Update Conference Call on February 22, 2021   GlobeNewswire Inc
Jan 8, 2021
10:53AM EST  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced registered direct offering (the Offering) of 6.0 million shares of common stock at a price of $2.24 per share which was priced at-the-market under Nasdaq rules.   GlobeNewswire Inc
Jan 6, 2021
09:29AM EST  PAVmed Announces Registered Direct Offering of its Common Stock   GlobeNewswire Inc
Dec 22, 2020
12:05PM EST  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced registered direct offering (the Offering) of approximately 5.1 million shares of common stock at a price of $1.60 per share.   GlobeNewswire Inc
Dec 18, 2020
09:29AM EST  PAVmed Announces Pricing of Additional $8.1 Million Common Stock   GlobeNewswire Inc
Dec 11, 2020
09:29AM EST  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, today announced it has entered into agreements for the sale of 5.6 million shares of common stock in a registered direct offering at a price of $1.60 per share for gross proceeds of approximately $8.9 million.   GlobeNewswire Inc
Nov 17, 2020
04:00PM EST  PAVmed Reports Third Quarter 2020 Financial Results and Provides   GlobeNewswire Inc
Nov 2, 2020
09:30AM EST  PAVmed to Hold Business Update Conference Call on November 17, 2020   GlobeNewswire Inc
Sep 8, 2020
09:30AM EDT  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a highly differentiated, multi-product, commercial-stage medical device company, today announced that Lishan Aklog, M.D., Chairman and Chief Executive Officer of the Company, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference onTuesday, September 15, 2020 from 8:00 a.m. to 8:30 a.m. Eastern time.   GlobeNewswire Inc
Aug 18, 2020
04:15PM EDT  PAVmed Reports Second Quarter 2020 Financial Results and Provides   GlobeNewswire Inc
Jul 28, 2020
09:30AM EDT  PAVmed to Hold Business Update Conference Call on August 18, 2020   GlobeNewswire Inc
Jul 13, 2020
09:30AM EDT  PAVmed to Present at Maxim Groups COVID-19   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC